<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Agencies of the European Union / Pharmaceuticals policy / Health / European Medicines Agency / European Union / Marketing authorization / Summary of Product Characteristics / Business
Date: 2016-07-07 08:05:52
Pharmaceutical industry
Agencies of the European Union
Pharmaceuticals policy
Health
European Medicines Agency
European Union
Marketing authorization
Summary of Product Characteristics
Business

BPGWorksharingEMA-CMDv

Add to Reading List

Source URL: www.hma.eu

Download Document from Source Website

File Size: 96,95 KB

Share Document on Facebook

Similar Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1  This medicinal product is subject to additional monitoring. This will allow quick identification of

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of

DocID: 1trcK - View Document

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1  1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.

DocID: 1tfLD - View Document

BPGWorksharingEMA-CMDv

BPGWorksharingEMA-CMDv

DocID: 1rr9m - View Document

B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDv

B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDv

DocID: 1rcFm - View Document

5th World Congress on Medicinal and Aromatic Plants WOCMAP 2014 Brisbane (Australia), 17-20 August 2014 New developments from the European Scientific Cooperative on Phytotherapy

5th World Congress on Medicinal and Aromatic Plants WOCMAP 2014 Brisbane (Australia), 17-20 August 2014 New developments from the European Scientific Cooperative on Phytotherapy

DocID: 1qSRs - View Document